Improving access to paediatric medicines

GAP-f works to accelerate the introduction and uptake of age-appropriate medicines worldwide by strengthening advocacy, monitoring access and delivery priorities, and promoting the adaptation and uptake of essential medicines for children at country level. Through collaboration with partners, it supports the development and implementation of practical product introduction tools, builds country capacity, and mobilises civil society and community-based organisations to generate demand and drive uptake. GAP-f also provides technical assistance to support partner-led product introduction, rollout and monitoring, ensuring appropriate use and effective assessment of safety and effectiveness. Regional initiatives, such as the three-year ASEAN programme supported by the Temasek Foundation, will demonstrate and scale integrated approaches to strengthen the paediatric medicines ecosystem and improving access to essential paediatric treatments across high-burden diseases.

Resources

Regional Workshop on Strengthening Paediatric Medicines Ecosystems in the ASEAN Region, Report of a WHO meeting, Kuala Lumpur, Malaysia, 11–13 May 2026

The Regional Workshop on Strengthening Paediatric Medicines Ecosystems in the ASEAN Region was convened in Kuala Lumpur, Malaysia, from 11–13 May...

Accelerating innovation and access to better medicines for children: advocacy brief

The objective of this brief is to mobilize global advocacy efforts to access better – safer, more effective and quality-assured – medicines...

Paediatric DTG implementation considerations for national programmes

In mid-2021, national HIV programmes began to transition treatment for children living with HIV to dolutegravir (DTG) 10 mg scored, dispersible tablets,...